Building on these human genetic findings, insitro's CellML™ platform was used to screen genetically supported targets in primary human adipocytes using high-content imaging, transcriptomics, and ...
Spurred by the discoveries of human pluripotent stem cell culture by James Thomson in the 1990s and the induction of pluripotency from adult cells by Shinya Yamanaka in the 2000s, therapeutics derived ...
NORTHBROOK, Ill., Oct. 2, 2025 /PRNewswire/ -- Endevica Bio, a clinical-stage biotechnology company pioneering peptide therapeutics for metabolic diseases, announced a major scientific breakthrough ...
Upstream Bio, Inc. (UPB) completed its IPO back in October 2024, raising approximately $293 million. This biotech is placing itself in a good position to do well because it is leveraging an entirely ...
OSSIO expands portfolio of highly differentiated bio-integrative fixation implants with small compression staples to enhance bunion repair patients’ satisfaction Revolutionary material science ...
The funding will support a GLP-1 pill Corxel licensed from China-based Vincentage in 2024 and that the company believes to be ...
Pleasanton, CA, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTC PK: PKBO), is a clinical-stage biopharmaceutical company focused on developing the next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results